speb/financial-data huggingface dataset:
BMNR cash_flow (quarterly, 2025-08-31) — Depreciation: 221946.00
BMNR cash_flow (annual, 2025-08-31) — Depreciation Amortization Depletion: 761000.00
BMNR cash_flow (quarterly, 2025-08-31) — Depreciation Amortization Depletion: 221946.00
BMNR cash_flow (annual, 2025-08-31) — Depreciation And Amortization: 761000.00
BMNR cash_flow (quarterly, 2025-08-31) — Depreciation And Amortization: 221946.00
BMNR income_statement (annual, 2025-08-31) — Diluted Average Shares: 24515226.00
BMNR income_statement (annual, 2025-08-31) — Diluted EPS: 13.39
BMNR income_statement (annual, 2025-08-31) — Diluted NI Availto Com Stockholders: 328161000.00
BMNR income_statement (quarterly, 2025-08-31) — Diluted NI Availto Com Stockholders: 333876039.00
BMNR income_statement (annual, 2025-08-31) — EBIT: 441117000.00
BMNR income_statement (quarterly, 2025-08-31) — EBIT: 443670592.00
BMNR income_statement (annual, 2025-08-31) — EBITDA: 441878000.00
BMNR income_statement (quarterly, 2025-08-31) — EBITDA: 443892538.00
BMNR income_statement (annual, 2025-08-31) — Earnings From Equity Interest: -1278000.00
BMNR cash_flow (annual, 2025-08-31) — Earnings Losses From Equity Investments: 1278000.00
BMNR cash_flow (annual, 2025-08-31) — End Cash Position: 511999000.00
BMNR cash_flow (quarterly, 2025-08-31) — End Cash Position: 511999000.00
BMNR cash_flow (annual, 2025-08-31) — Financing Cash Flow: 7947659000.00
BMNR cash_flow (quarterly, 2025-08-31) — Financing Cash Flow: 7948032637.00
BMNR cash_flow (annual, 2025-08-31) — Free Cash Flow: -5214000.00
BMNR cash_flow (quarterly, 2025-08-31) — Free Cash Flow: -6561868.00
BMNR cash_flow (annual, 2025-08-31) — Gain Loss On Investment Securities: -3748000.00
BMNR cash_flow (annual, 2025-08-31) — Gain Loss On Sale Of PPE: 1528000.00
BMNR cash_flow (quarterly, 2025-08-31) — Gain Loss On Sale Of PPE: 1574768.00
BMNR income_statement (annual, 2025-08-31) — Gain On Sale Of Ppe: 2220000.00
BMNR income_statement (annual, 2025-08-31) — General And Administrative Expense: 13984000.00
BMNR income_statement (quarterly, 2025-08-31) — General And Administrative Expense: 12456932.00
BMNR balance_sheet (annual, 2025-08-31) — Gross PPE: 669000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Gross PPE: 669000.00
BMNR income_statement (annual, 2025-08-31) — Gross Profit: 310000.00
BMNR income_statement (quarterly, 2025-08-31) — Gross Profit: -605794.00
BMNR income_statement (annual, 2025-08-31) — Impairment Of Capital Assets: 1912000.00
BMNR income_statement (annual, 2025-08-31) — Interest Expense: 245000.00
BMNR income_statement (quarterly, 2025-08-31) — Interest Expense: 44202.00
BMNR income_statement (annual, 2025-08-31) — Interest Expense Non Operating: 245000.00
BMNR income_statement (quarterly, 2025-08-31) — Interest Expense Non Operating: 44202.00
BMNR income_statement (annual, 2025-08-31) — Interest Income: 1000.00
BMNR income_statement (quarterly, 2025-08-31) — Interest Income: 281.00
BMNR income_statement (annual, 2025-08-31) — Interest Income Non Operating: 1000.00
BMNR income_statement (quarterly, 2025-08-31) — Interest Income Non Operating: 281.00
BMNR balance_sheet (annual, 2025-08-31) — Invested Capital: 8692797000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Invested Capital: 8692797000.00
BMNR cash_flow (annual, 2025-08-31) — Investing Cash Flow: -7432009000.00
BMNR cash_flow (quarterly, 2025-08-31) — Investing Cash Flow: -7431991000.00
BMNR cash_flow (annual, 2025-08-31) — Issuance Of Capital Stock: 7948276000.00
BMNR cash_flow (quarterly, 2025-08-31) — Issuance Of Capital Stock: 7948051000.00
BMNR cash_flow (annual, 2025-08-31) — Issuance Of Debt: 1285000.00
BMNR cash_flow (quarterly, 2025-08-31) — Issuance Of Debt: 1035000.00
BMNR cash_flow (annual, 2025-08-31) — Net Business Purchase And Sale: 0.00
BMNR cash_flow (quarterly, 2025-08-31) — Net Business Purchase And Sale: 0.00
BMNR cash_flow (annual, 2025-08-31) — Net Common Stock Issuance: 7948051000.00
BMNR income_statement (annual, 2025-08-31) — Net Income: 348577000.00
BMNR income_statement (quarterly, 2025-08-31) — Net Income: 351331391.00
BMNR income_statement (annual, 2025-08-31) — Net Income Common Stockholders: 328161000.00
BMNR income_statement (quarterly, 2025-08-31) — Net Income Common Stockholders: 333876039.00
BMNR income_statement (annual, 2025-08-31) — Net Income Continuous Operations: 348577000.00
BMNR income_statement (quarterly, 2025-08-31) — Net Income Continuous Operations: 351331390.00
BMNR income_statement (annual, 2025-08-31) — Net Income From Continuing And Discontinued Operation: 348577000.00
BMNR income_statement (quarterly, 2025-08-31) — Net Income From Continuing And Discontinued Operation: 351331391.00
BMNR income_statement (annual, 2025-08-31) — Net Income From Continuing Operation Net Minority Interest: 348577000.00
BMNR income_statement (quarterly, 2025-08-31) — Net Income From Continuing Operation Net Minority Interest: 351331391.00
BMNR cash_flow (annual, 2025-08-31) — Net Income From Continuing Operations: 348577000.00
BMNR cash_flow (quarterly, 2025-08-31) — Net Income From Continuing Operations: 351331391.00
BMNR income_statement (annual, 2025-08-31) — Net Income Including Noncontrolling Interests: 348577000.00
BMNR income_statement (quarterly, 2025-08-31) — Net Income Including Noncontrolling Interests: 351331391.00
BMNR income_statement (annual, 2025-08-31) — Net Interest Income: -244000.00
BMNR income_statement (quarterly, 2025-08-31) — Net Interest Income: -43921.00
BMNR cash_flow (annual, 2025-08-31) — Net Investment Purchase And Sale: -7430944000.00
BMNR cash_flow (annual, 2025-08-31) — Net Issuance Payments Of Debt: -617000.00
BMNR cash_flow (quarterly, 2025-08-31) — Net Issuance Payments Of Debt: -18363.00
BMNR income_statement (annual, 2025-08-31) — Net Non Operating Interest Income Expense: -244000.00
BMNR income_statement (quarterly, 2025-08-31) — Net Non Operating Interest Income Expense: -43921.00
BMNR balance_sheet (annual, 2025-08-31) — Net PPE: 516000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Net PPE: 516000.00
BMNR cash_flow (annual, 2025-08-31) — Net PPE Purchase And Sale: -1065000.00
BMNR cash_flow (quarterly, 2025-08-31) — Net PPE Purchase And Sale: -1047000.00
BMNR cash_flow (annual, 2025-08-31) — Net Preferred Stock Issuance: 225000.00
BMNR cash_flow (quarterly, 2025-08-31) — Net Preferred Stock Issuance: 0.00
BMNR cash_flow (annual, 2025-08-31) — Net Short Term Debt Issuance: -617000.00
BMNR cash_flow (quarterly, 2025-08-31) — Net Short Term Debt Issuance: -18363.00
BMNR balance_sheet (annual, 2025-08-31) — Net Tangible Assets: 8692797000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Net Tangible Assets: 8692797000.00
BMNR balance_sheet (annual, 2025-08-31) — Non Current Deferred Liabilities: 92295000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Non Current Deferred Liabilities: 92295000.00
BMNR balance_sheet (annual, 2025-08-31) — Non Current Deferred Revenue: 0.00
BMNR balance_sheet (quarterly, 2025-08-31) — Non Current Deferred Revenue: 0.00
BMNR balance_sheet (annual, 2025-08-31) — Non Current Deferred Taxes Liabilities: 92295000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Non Current Deferred Taxes Liabilities: 92295000.00
BMNR income_statement (annual, 2025-08-31) — Normalized EBITDA: 441859000.00
BMNR income_statement (quarterly, 2025-08-31) — Normalized EBITDA: 443584820.00
BMNR income_statement (annual, 2025-08-31) — Normalized Income: 348561971.00
BMNR income_statement (quarterly, 2025-08-31) — Normalized Income: 351088293.78
BMNR cash_flow (annual, 2025-08-31) — Operating Cash Flow: -4149000.00
BMNR cash_flow (quarterly, 2025-08-31) — Operating Cash Flow: -5514868.00
BMNR cash_flow (annual, 2025-08-31) — Operating Gains Losses: -653000.00
BMNR cash_flow (quarterly, 2025-08-31) — Operating Gains Losses: -606232.00
BMNR income_statement (annual, 2025-08-31) — Operating Income: -362633000.00
BMNR income_statement (quarterly, 2025-08-31) — Operating Income: -360342674.00
BMNR income_statement (annual, 2025-08-31) — Operating Revenue: 6095000.00
BMNR income_statement (quarterly, 2025-08-31) — Operating Revenue: 1324891.00
BMNR balance_sheet (annual, 2025-08-31) — Ordinary Shares Number: 234714000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Ordinary Shares Number: 234714000.00
BMNR income_statement (annual, 2025-08-31) — Other Gand A: 13984000.00
BMNR income_statement (quarterly, 2025-08-31) — Other Gand A: 13263540.00
BMNR income_statement (annual, 2025-08-31) — Other Income Expense: 803749000.00
BMNR income_statement (quarterly, 2025-08-31) — Other Income Expense: 804012985.00
BMNR cash_flow (annual, 2025-08-31) — Other Non Cash Items: 348967000.00
BMNR cash_flow (quarterly, 2025-08-31) — Other Non Cash Items: 348974723.00
BMNR balance_sheet (annual, 2025-08-31) — Other Non Current Assets: 8281530000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Other Non Current Assets: 8281530000.00
BMNR income_statement (annual, 2025-08-31) — Other Non Operating Income Expenses: 805008000.00
BMNR income_statement (quarterly, 2025-08-31) — Other Non Operating Income Expenses: 804983267.00
BMNR income_statement (annual, 2025-08-31) — Other Operating Expenses: 348959000.00
BMNR income_statement (quarterly, 2025-08-31) — Other Operating Expenses: 347819002.00
BMNR balance_sheet (annual, 2025-08-31) — Other Properties: 669000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Other Properties: 669000.00
BMNR balance_sheet (annual, 2025-08-31) — Other Receivables: 510000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Other Receivables: 510000.00
BMNR income_statement (annual, 2025-08-31) — Other Special Charges: 289000.00
BMNR income_statement (quarterly, 2025-08-31) — Other Special Charges: 282.00
BMNR income_statement (annual, 2025-08-31) — Otherunder Preferred Stock Dividend: 17455000.00
BMNR balance_sheet (annual, 2025-08-31) — Payables And Accrued Expenses: 8894000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Payables And Accrued Expenses: 8894000.00
BMNR balance_sheet (annual, 2025-08-31) — Preferred Stock: 0.00
BMNR balance_sheet (quarterly, 2025-08-31) — Preferred Stock: 0.00
BMNR income_statement (annual, 2025-08-31) — Preferred Stock Dividends: 2961000.00
BMNR income_statement (quarterly, 2025-08-31) — Preferred Stock Dividends: 352.00
BMNR cash_flow (annual, 2025-08-31) — Preferred Stock Issuance: 225000.00
BMNR cash_flow (quarterly, 2025-08-31) — Preferred Stock Issuance: 0.00
BMNR balance_sheet (annual, 2025-08-31) — Prepaid Assets: 498000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Prepaid Assets: 498000.00
BMNR income_statement (annual, 2025-08-31) — Pretax Income: 440872000.00
BMNR income_statement (quarterly, 2025-08-31) — Pretax Income: 443626390.00
BMNR balance_sheet (annual, 2025-08-31) — Properties: 369000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Properties: 369000.00
BMNR cash_flow (annual, 2025-08-31) — Purchase Of Investment: -7433131000.00
BMNR cash_flow (annual, 2025-08-31) — Purchase Of PPE: -1065000.00
BMNR cash_flow (quarterly, 2025-08-31) — Purchase Of PPE: -1047000.00
BMNR balance_sheet (annual, 2025-08-31) — Receivables: 510000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Receivables: 510000.00
BMNR income_statement (annual, 2025-08-31) — Reconciled Cost Of Revenue: 5785000.00
BMNR income_statement (quarterly, 2025-08-31) — Reconciled Cost Of Revenue: 1930685.00
BMNR income_statement (annual, 2025-08-31) — Reconciled Depreciation: 761000.00
BMNR income_statement (quarterly, 2025-08-31) — Reconciled Depreciation: 221946.00
BMNR cash_flow (annual, 2025-08-31) — Repayment Of Debt: -1902000.00
BMNR cash_flow (quarterly, 2025-08-31) — Repayment Of Debt: -1053363.00
BMNR balance_sheet (annual, 2025-08-31) — Retained Earnings: 337392000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Retained Earnings: 337392000.00
BMNR cash_flow (annual, 2025-08-31) — Sale Of Business: 0.00
BMNR cash_flow (quarterly, 2025-08-31) — Sale Of Business: 0.00
BMNR cash_flow (annual, 2025-08-31) — Sale Of Investment: 2187000.00
BMNR income_statement (annual, 2025-08-31) — Selling General And Administration: 13984000.00
BMNR income_statement (quarterly, 2025-08-31) — Selling General And Administration: 12456932.00
BMNR balance_sheet (annual, 2025-08-31) — Share Issued: 234714000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Share Issued: 234714000.00
BMNR cash_flow (annual, 2025-08-31) — Short Term Debt Issuance: 1285000.00
BMNR cash_flow (quarterly, 2025-08-31) — Short Term Debt Issuance: 1035000.00
BMNR cash_flow (annual, 2025-08-31) — Short Term Debt Payments: -1902000.00
BMNR cash_flow (quarterly, 2025-08-31) — Short Term Debt Payments: -1053363.00
BMNR income_statement (annual, 2025-08-31) — Special Income Charges: 19000.00
BMNR income_statement (quarterly, 2025-08-31) — Special Income Charges: 307718.00
BMNR cash_flow (annual, 2025-08-31) — Stock Based Compensation: 2425000.00
BMNR cash_flow (quarterly, 2025-08-31) — Stock Based Compensation: 1105654.00
BMNR balance_sheet (annual, 2025-08-31) — Stockholders Equity: 8692797000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Stockholders Equity: 8692797000.00
BMNR balance_sheet (annual, 2025-08-31) — Tangible Book Value: 8692797000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Tangible Book Value: 8692797000.00
BMNR income_statement (annual, 2025-08-31) — Tax Effect Of Unusual Items: 3971.00
BMNR income_statement (quarterly, 2025-08-31) — Tax Effect Of Unusual Items: 64620.78
BMNR income_statement (annual, 2025-08-31) — Tax Provision: 92295000.00
BMNR income_statement (annual, 2025-08-31) — Tax Rate For Calcs: 0.21
BMNR income_statement (quarterly, 2025-08-31) — Tax Rate For Calcs: 0.21
BMNR balance_sheet (annual, 2025-08-31) — Total Assets: 8795053000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Total Assets: 8795053000.00
BMNR balance_sheet (annual, 2025-08-31) — Total Capitalization: 8692797000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Total Capitalization: 8692797000.00
BMNR balance_sheet (annual, 2025-08-31) — Total Equity Gross Minority Interest: 8692797000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Total Equity Gross Minority Interest: 8692797000.00
BMNR income_statement (annual, 2025-08-31) — Total Expenses: 368728000.00
BMNR income_statement (quarterly, 2025-08-31) — Total Expenses: 361667565.00
BMNR balance_sheet (annual, 2025-08-31) — Total Liabilities Net Minority Interest: 102256000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Total Liabilities Net Minority Interest: 102256000.00
BMNR balance_sheet (annual, 2025-08-31) — Total Non Current Assets: 8282046000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Total Non Current Assets: 8282046000.00
BMNR balance_sheet (annual, 2025-08-31) — Total Non Current Liabilities Net Minority Interest: 92295000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Total Non Current Liabilities Net Minority Interest: 92295000.00
BMNR income_statement (annual, 2025-08-31) — Total Operating Income As Reported: 444211000.00
BMNR income_statement (quarterly, 2025-08-31) — Total Operating Income As Reported: 446476594.00
BMNR income_statement (annual, 2025-08-31) — Total Unusual Items: 19000.00
BMNR income_statement (quarterly, 2025-08-31) — Total Unusual Items: 307718.00
BMNR income_statement (annual, 2025-08-31) — Total Unusual Items Excluding Goodwill: 19000.00
BMNR income_statement (quarterly, 2025-08-31) — Total Unusual Items Excluding Goodwill: 307718.00
BMNR cash_flow (annual, 2025-08-31) — Unrealized Gain Loss On Investment Securities: -805008000.00
BMNR balance_sheet (annual, 2025-08-31) — Working Capital: 503046000.00
BMNR balance_sheet (quarterly, 2025-08-31) — Working Capital: 503046000.00
BMNR income_statement (quarterly, 2025-11-30) — +Operating Expense: 5455471000.00
BMNR income_statement (quarterly, 2025-11-30) — +Total Revenue: 2293000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Accumulated Depreciation: -277000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Additional Paid In Capital: 16118194000.00
BMNR cash_flow (quarterly, 2025-11-30) — Asset Impairment Charge: 200000.00
BMNR income_statement (quarterly, 2025-11-30) — Basic Average Shares: 325665565.00
BMNR income_statement (quarterly, 2025-11-30) — Basic EPS: -15.98
BMNR cash_flow (quarterly, 2025-11-30) — Beginning Cash Position: 511999000.00
BMNR cash_flow (quarterly, 2025-11-30) — Capital Expenditure: -376000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Capital Stock: 41000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 887678000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Short Term Investments: 887678000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Cash Equivalents: 887678000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Cash Financial: 887678000.00
BMNR cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Financing Activities: 8026474000.00
BMNR cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Investing Activities: -7422439000.00
BMNR cash_flow (quarterly, 2025-11-30) — Cash Flow From Continuing Operating Activities: -228356000.00
BMNR cash_flow (quarterly, 2025-11-30) — Change In Accrued Expense: 4329000.00
BMNR cash_flow (quarterly, 2025-11-30) — Change In Other Current Assets: 371000.00
BMNR cash_flow (quarterly, 2025-11-30) — Change In Other Working Capital: -92572000.00
BMNR cash_flow (quarterly, 2025-11-30) — Change In Payables And Accrued Expense: 4329000.00
BMNR cash_flow (quarterly, 2025-11-30) — Change In Prepaid Assets: -621000.00
BMNR cash_flow (quarterly, 2025-11-30) — Change In Receivables: -231000.00
BMNR cash_flow (quarterly, 2025-11-30) — Change In Working Capital: -88724000.00
BMNR cash_flow (quarterly, 2025-11-30) — Changes In Cash: 375679000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Common Stock: 41000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 11251532000.00
BMNR cash_flow (quarterly, 2025-11-30) — Common Stock Issuance: 7664380000.00
BMNR income_statement (quarterly, 2025-11-30) — Cost Of Revenue: 1024000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Current Accrued Expenses: 11338000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Current Assets: 889028000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Current Deferred Liabilities: 790000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Current Deferred Revenue: 790000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Current Liabilities: 137128000.00
BMNR cash_flow (quarterly, 2025-11-30) — Depreciation: 124000.00
BMNR cash_flow (quarterly, 2025-11-30) — Depreciation Amortization Depletion: 124000.00
BMNR cash_flow (quarterly, 2025-11-30) — Depreciation And Amortization: 124000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Derivative Product Liabilities: 98615000.00
BMNR income_statement (quarterly, 2025-11-30) — Diluted Average Shares: 325665565.00
BMNR income_statement (quarterly, 2025-11-30) — Diluted EPS: -15.98
BMNR income_statement (quarterly, 2025-11-30) — Diluted NI Availto Com Stockholders: -5204095000.00
BMNR income_statement (quarterly, 2025-11-30) — EBIT: -5296190000.00
BMNR income_statement (quarterly, 2025-11-30) — EBITDA: -5296066000.00
BMNR cash_flow (quarterly, 2025-11-30) — End Cash Position: 887678000.00
BMNR cash_flow (quarterly, 2025-11-30) — Financing Cash Flow: 8026474000.00
BMNR cash_flow (quarterly, 2025-11-30) — Free Cash Flow: -228732000.00
BMNR cash_flow (quarterly, 2025-11-30) — Gain Loss On Investment Securities: -167593000.00
BMNR income_statement (quarterly, 2025-11-30) — Gain On Sale Of Security: 158212000.00
BMNR income_statement (quarterly, 2025-11-30) — General And Administrative Expense: 223436000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Gross PPE: 845000.00
BMNR income_statement (quarterly, 2025-11-30) — Gross Profit: 1269000.00
BMNR income_statement (quarterly, 2025-11-30) — Impairment Of Capital Assets: 200000.00
BMNR income_statement (quarterly, 2025-11-30) — Interest Expense: 200000.00
BMNR income_statement (quarterly, 2025-11-30) — Interest Expense Non Operating: 200000.00
BMNR income_statement (quarterly, 2025-11-30) — Interest Income: 0.00
BMNR income_statement (quarterly, 2025-11-30) — Interest Income Non Operating: 0.00
BMNR balance_sheet (quarterly, 2025-11-30) — Invested Capital: 11251532000.00
BMNR cash_flow (quarterly, 2025-11-30) — Investing Cash Flow: -7422439000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Investments And Advances: 35890000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Investments In Other Ventures Under Equity Method: 35890000.00
BMNR cash_flow (quarterly, 2025-11-30) — Issuance Of Capital Stock: 7664380000.00
BMNR cash_flow (quarterly, 2025-11-30) — Issuance Of Debt: 0.00
BMNR balance_sheet (quarterly, 2025-11-30) — Long Term Equity Investment: 35890000.00
BMNR cash_flow (quarterly, 2025-11-30) — Net Common Stock Issuance: 7664380000.00
BMNR income_statement (quarterly, 2025-11-30) — Net Income: -5204095000.00
BMNR income_statement (quarterly, 2025-11-30) — Net Income Common Stockholders: -5204095000.00
BMNR income_statement (quarterly, 2025-11-30) — Net Income Continuous Operations: -5204095000.00
BMNR income_statement (quarterly, 2025-11-30) — Net Income From Continuing And Discontinued Operation: -5204095000.00
BMNR income_statement (quarterly, 2025-11-30) — Net Income From Continuing Operation Net Minority Interest: -5204095000.00
BMNR cash_flow (quarterly, 2025-11-30) — Net Income From Continuing Operations: -5204095000.00
BMNR income_statement (quarterly, 2025-11-30) — Net Income Including Noncontrolling Interests: -5204095000.00
BMNR income_statement (quarterly, 2025-11-30) — Net Interest Income: -200000.00
BMNR cash_flow (quarterly, 2025-11-30) — Net Investment Purchase And Sale: -7422573000.00
BMNR cash_flow (quarterly, 2025-11-30) — Net Issuance Payments Of Debt: 0.00
BMNR income_statement (quarterly, 2025-11-30) — Net Non Operating Interest Income Expense: -200000.00
BMNR cash_flow (quarterly, 2025-11-30) — Net Other Financing Charges: 361751000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Net PPE: 568000.00
BMNR cash_flow (quarterly, 2025-11-30) — Net PPE Purchase And Sale: 134000.00
BMNR cash_flow (quarterly, 2025-11-30) — Net Preferred Stock Issuance: 0.00
BMNR cash_flow (quarterly, 2025-11-30) — Net Short Term Debt Issuance: 0.00
BMNR balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 11251532000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Non Current Deferred Liabilities: 0.00
BMNR balance_sheet (quarterly, 2025-11-30) — Non Current Deferred Taxes Liabilities: 0.00
BMNR income_statement (quarterly, 2025-11-30) — Normalized EBITDA: -5454078000.00
BMNR income_statement (quarterly, 2025-11-30) — Normalized Income: -5359357591.20
BMNR cash_flow (quarterly, 2025-11-30) — Operating Cash Flow: -228356000.00
BMNR cash_flow (quarterly, 2025-11-30) — Operating Gains Losses: -167593000.00
BMNR income_statement (quarterly, 2025-11-30) — Operating Income: -5454202000.00
BMNR income_statement (quarterly, 2025-11-30) — Operating Revenue: 2293000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 408578823.00
BMNR balance_sheet (quarterly, 2025-11-30) — Other Current Liabilities: 125000000.00
BMNR income_statement (quarterly, 2025-11-30) — Other Gand A: 223436000.00
BMNR income_statement (quarterly, 2025-11-30) — Other Income Expense: 158012000.00
BMNR cash_flow (quarterly, 2025-11-30) — Other Non Cash Items: -980000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Other Non Current Assets: 10561789000.00
BMNR income_statement (quarterly, 2025-11-30) — Other Operating Expenses: 5232035000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Other Properties: 845000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Other Receivables: 231000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Payables And Accrued Expenses: 11338000.00
BMNR cash_flow (quarterly, 2025-11-30) — Preferred Stock Issuance: 0.00
BMNR balance_sheet (quarterly, 2025-11-30) — Prepaid Assets: 1119000.00
BMNR income_statement (quarterly, 2025-11-30) — Pretax Income: -5296390000.00
BMNR cash_flow (quarterly, 2025-11-30) — Proceeds From Stock Option Exercised: 343000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Properties: 745000.00
BMNR cash_flow (quarterly, 2025-11-30) — Purchase Of Investment: -7422573000.00
BMNR cash_flow (quarterly, 2025-11-30) — Purchase Of PPE: -376000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Receivables: 231000.00
BMNR income_statement (quarterly, 2025-11-30) — Reconciled Cost Of Revenue: 1024000.00
BMNR income_statement (quarterly, 2025-11-30) — Reconciled Depreciation: 124000.00
BMNR cash_flow (quarterly, 2025-11-30) — Repayment Of Debt: 0.00
BMNR balance_sheet (quarterly, 2025-11-30) — Retained Earnings: -4866703000.00
BMNR cash_flow (quarterly, 2025-11-30) — Sale Of PPE: 510000.00
BMNR income_statement (quarterly, 2025-11-30) — Selling General And Administration: 223436000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Share Issued: 408578823.00
BMNR cash_flow (quarterly, 2025-11-30) — Short Term Debt Issuance: 0.00
BMNR cash_flow (quarterly, 2025-11-30) — Short Term Debt Payments: 0.00
BMNR income_statement (quarterly, 2025-11-30) — Special Income Charges: -200000.00
BMNR cash_flow (quarterly, 2025-11-30) — Stock Based Compensation: 677000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 11251532000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 11251532000.00
BMNR income_statement (quarterly, 2025-11-30) — Tax Effect Of Unusual Items: 2749408.80
BMNR income_statement (quarterly, 2025-11-30) — Tax Provision: -92295000.00
BMNR income_statement (quarterly, 2025-11-30) — Tax Rate For Calcs: 0.02
BMNR balance_sheet (quarterly, 2025-11-30) — Total Assets: 11487275000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Total Capitalization: 11251532000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 11251532000.00
BMNR income_statement (quarterly, 2025-11-30) — Total Expenses: 5456495000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 235743000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Total Non Current Assets: 10598247000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Total Non Current Liabilities Net Minority Interest: 98615000.00
BMNR income_statement (quarterly, 2025-11-30) — Total Operating Income As Reported: -5470292000.00
BMNR income_statement (quarterly, 2025-11-30) — Total Unusual Items: 158012000.00
BMNR income_statement (quarterly, 2025-11-30) — Total Unusual Items Excluding Goodwill: 158012000.00
BMNR cash_flow (quarterly, 2025-11-30) — Unrealized Gain Loss On Investment Securities: 5232035000.00
BMNR balance_sheet (quarterly, 2025-11-30) — Working Capital: 751900000.00
BMNR income_statement (quarterly, 2026-02-28) — +Operating Expense: 3871704000.00
BMNR income_statement (quarterly, 2026-02-28) — +Total Revenue: 11041000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Accumulated Depreciation: -401000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Additional Paid In Capital: 18547413000.00
BMNR cash_flow (quarterly, 2026-02-28) — Asset Impairment Charge: 0.00
BMNR income_statement (quarterly, 2026-02-28) — Basic Average Shares: 454620613.00
BMNR income_statement (quarterly, 2026-02-28) — Basic EPS: -8.40
BMNR cash_flow (quarterly, 2026-02-28) — Beginning Cash Position: 887678000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Buildings And Improvements: 1320000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Capital Lease Obligations: 1244000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Capital Stock: 49000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Cash And Cash Equivalents: 879577000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Cash Cash Equivalents And Short Term Investments: 879577000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Cash Equivalents: 879577000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Cash Financial: 879577000.00
BMNR cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Financing Activities: 2400488000.00
BMNR cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Investing Activities: -2320346000.00
BMNR cash_flow (quarterly, 2026-02-28) — Cash Flow From Continuing Operating Activities: -88243000.00
BMNR cash_flow (quarterly, 2026-02-28) — Change In Accrued Expense: 2603000.00
BMNR cash_flow (quarterly, 2026-02-28) — Change In Other Current Assets: -106000.00
BMNR cash_flow (quarterly, 2026-02-28) — Change In Other Working Capital: -621000.00
BMNR cash_flow (quarterly, 2026-02-28) — Change In Payables And Accrued Expense: 2603000.00
BMNR cash_flow (quarterly, 2026-02-28) — Change In Prepaid Assets: -4429000.00
BMNR cash_flow (quarterly, 2026-02-28) — Change In Receivables: -520000.00
BMNR cash_flow (quarterly, 2026-02-28) — Change In Working Capital: -66134000.00
BMNR cash_flow (quarterly, 2026-02-28) — Changes In Cash: -8101000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Common Stock: 49000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Common Stock Equity: 9858088000.00
BMNR cash_flow (quarterly, 2026-02-28) — Common Stock Issuance: 2404534000.00
BMNR income_statement (quarterly, 2026-02-28) — Cost Of Revenue: 1426000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Current Accrued Expenses: 13568000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Current Assets: 885876000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Current Deferred Liabilities: 169000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Current Deferred Revenue: 169000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Current Liabilities: 16349000.00
BMNR cash_flow (quarterly, 2026-02-28) — Depreciation: 124000.00
BMNR cash_flow (quarterly, 2026-02-28) — Depreciation Amortization Depletion: 124000.00
BMNR cash_flow (quarterly, 2026-02-28) — Depreciation And Amortization: 124000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Derivative Product Liabilities: 18575000.00
BMNR income_statement (quarterly, 2026-02-28) — Diluted Average Shares: 454620613.00
BMNR income_statement (quarterly, 2026-02-28) — Diluted EPS: -8.40
BMNR income_statement (quarterly, 2026-02-28) — Diluted NI Availto Com Stockholders: -3818413000.00
BMNR income_statement (quarterly, 2026-02-28) — EBIT: -3862089000.00
BMNR income_statement (quarterly, 2026-02-28) — EBITDA: -3861965000.00
BMNR cash_flow (quarterly, 2026-02-28) — End Cash Position: 879577000.00
BMNR cash_flow (quarterly, 2026-02-28) — Financing Cash Flow: 2400488000.00
BMNR cash_flow (quarterly, 2026-02-28) — Free Cash Flow: -88243000.00
BMNR cash_flow (quarterly, 2026-02-28) — Gain Loss On Investment Securities: -14768000.00
BMNR income_statement (quarterly, 2026-02-28) — Gain On Sale Of Security: 38858000.00
BMNR income_statement (quarterly, 2026-02-28) — General And Administrative Expense: 74988000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Gross PPE: 2065000.00
BMNR income_statement (quarterly, 2026-02-28) — Gross Profit: 9615000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Invested Capital: 9858088000.00
BMNR cash_flow (quarterly, 2026-02-28) — Investing Cash Flow: -2320346000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Investments And Advances: 200408000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Investments In Other Ventures Under Equity Method: 200408000.00
BMNR cash_flow (quarterly, 2026-02-28) — Issuance Of Capital Stock: 2404534000.00
BMNR cash_flow (quarterly, 2026-02-28) — Issuance Of Debt: 0.00
BMNR balance_sheet (quarterly, 2026-02-28) — Long Term Capital Lease Obligation: 1244000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Long Term Debt And Capital Lease Obligation: 1244000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Long Term Equity Investment: 200408000.00
BMNR cash_flow (quarterly, 2026-02-28) — Net Common Stock Issuance: 2404534000.00
BMNR income_statement (quarterly, 2026-02-28) — Net Income: -3818413000.00
BMNR income_statement (quarterly, 2026-02-28) — Net Income Common Stockholders: -3818413000.00
BMNR income_statement (quarterly, 2026-02-28) — Net Income Continuous Operations: -3818413000.00
BMNR income_statement (quarterly, 2026-02-28) — Net Income From Continuing And Discontinued Operation: -3818413000.00
BMNR income_statement (quarterly, 2026-02-28) — Net Income From Continuing Operation Net Minority Interest: -3818413000.00
BMNR cash_flow (quarterly, 2026-02-28) — Net Income From Continuing Operations: -3818413000.00
BMNR income_statement (quarterly, 2026-02-28) — Net Income Including Noncontrolling Interests: -3818413000.00
BMNR income_statement (quarterly, 2026-02-28) — Net Interest Income: 4817000.00
BMNR cash_flow (quarterly, 2026-02-28) — Net Investment Purchase And Sale: -2320446000.00
BMNR cash_flow (quarterly, 2026-02-28) — Net Issuance Payments Of Debt: 0.00
BMNR income_statement (quarterly, 2026-02-28) — Net Non Operating Interest Income Expense: 4817000.00
BMNR cash_flow (quarterly, 2026-02-28) — Net Other Financing Charges: 0.00
BMNR balance_sheet (quarterly, 2026-02-28) — Net PPE: 1664000.00
BMNR cash_flow (quarterly, 2026-02-28) — Net PPE Purchase And Sale: 100000.00
BMNR cash_flow (quarterly, 2026-02-28) — Net Preferred Stock Issuance: 0.00
BMNR cash_flow (quarterly, 2026-02-28) — Net Short Term Debt Issuance: 0.00
BMNR balance_sheet (quarterly, 2026-02-28) — Net Tangible Assets: 9858088000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Liabilities: 0.00
BMNR balance_sheet (quarterly, 2026-02-28) — Non Current Deferred Taxes Liabilities: 0.00
BMNR income_statement (quarterly, 2026-02-28) — Normalized EBITDA: -3900823000.00
BMNR income_statement (quarterly, 2026-02-28) — Normalized Income: -3857271000.00
BMNR cash_flow (quarterly, 2026-02-28) — Operating Cash Flow: -88243000.00
BMNR cash_flow (quarterly, 2026-02-28) — Operating Gains Losses: -14768000.00
BMNR income_statement (quarterly, 2026-02-28) — Operating Income: -3862089000.00
BMNR income_statement (quarterly, 2026-02-28) — Operating Revenue: 11041000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Ordinary Shares Number: 493905227.00
BMNR balance_sheet (quarterly, 2026-02-28) — Other Current Liabilities: 2291000.00
BMNR income_statement (quarterly, 2026-02-28) — Other Gand A: 74988000.00
BMNR income_statement (quarterly, 2026-02-28) — Other Income Expense: 38859000.00
BMNR cash_flow (quarterly, 2026-02-28) — Other Non Cash Items: -10196000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Other Non Current Assets: 8806308000.00
BMNR income_statement (quarterly, 2026-02-28) — Other Non Operating Income Expenses: 1000.00
BMNR income_statement (quarterly, 2026-02-28) — Other Operating Expenses: 3796716000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Other Properties: 745000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Other Receivables: 751000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Payables And Accrued Expenses: 13568000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Pensionand Other Post Retirement Benefit Plans Current: 321000.00
BMNR cash_flow (quarterly, 2026-02-28) — Preferred Stock Issuance: 0.00
BMNR balance_sheet (quarterly, 2026-02-28) — Prepaid Assets: 5548000.00
BMNR income_statement (quarterly, 2026-02-28) — Pretax Income: -3818413000.00
BMNR cash_flow (quarterly, 2026-02-28) — Proceeds From Stock Option Exercised: 212000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Properties: 0.00
BMNR cash_flow (quarterly, 2026-02-28) — Purchase Of Investment: -2320446000.00
BMNR cash_flow (quarterly, 2026-02-28) — Purchase Of PPE: 0.00
BMNR balance_sheet (quarterly, 2026-02-28) — Receivables: 751000.00
BMNR income_statement (quarterly, 2026-02-28) — Reconciled Cost Of Revenue: 1426000.00
BMNR income_statement (quarterly, 2026-02-28) — Reconciled Depreciation: 124000.00
BMNR cash_flow (quarterly, 2026-02-28) — Repayment Of Debt: 0.00
BMNR balance_sheet (quarterly, 2026-02-28) — Retained Earnings: -8689374000.00
BMNR cash_flow (quarterly, 2026-02-28) — Sale Of PPE: 100000.00
BMNR income_statement (quarterly, 2026-02-28) — Selling General And Administration: 74988000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Share Issued: 493905227.00
BMNR cash_flow (quarterly, 2026-02-28) — Short Term Debt Issuance: 0.00
BMNR cash_flow (quarterly, 2026-02-28) — Short Term Debt Payments: 0.00
BMNR income_statement (quarterly, 2026-02-28) — Special Income Charges: 0.00
BMNR cash_flow (quarterly, 2026-02-28) — Stock Based Compensation: 24429000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Stockholders Equity: 9858088000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Tangible Book Value: 9858088000.00
BMNR income_statement (quarterly, 2026-02-28) — Tax Effect Of Unusual Items: 0.00
BMNR income_statement (quarterly, 2026-02-28) — Tax Provision: 0.00
BMNR income_statement (quarterly, 2026-02-28) — Tax Rate For Calcs: 0.00
BMNR balance_sheet (quarterly, 2026-02-28) — Total Assets: 9894256000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Total Capitalization: 9858088000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Total Debt: 1244000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Total Equity Gross Minority Interest: 9858088000.00
BMNR income_statement (quarterly, 2026-02-28) — Total Expenses: 3873130000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Total Liabilities Net Minority Interest: 36168000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Total Non Current Assets: 9008380000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Total Non Current Liabilities Net Minority Interest: 19819000.00
BMNR income_statement (quarterly, 2026-02-28) — Total Operating Income As Reported: -3840582000.00
BMNR income_statement (quarterly, 2026-02-28) — Total Other Finance Cost: -4817000.00
BMNR income_statement (quarterly, 2026-02-28) — Total Unusual Items: 38858000.00
BMNR income_statement (quarterly, 2026-02-28) — Total Unusual Items Excluding Goodwill: 38858000.00
BMNR cash_flow (quarterly, 2026-02-28) — Unrealized Gain Loss On Investment Securities: 3796715000.00
BMNR balance_sheet (quarterly, 2026-02-28) — Working Capital: 869527000.00
BMNR income_statement (quarterly, 2026-02-28) — Write Off: 0.00
BMNR income_statement (quarterly, 2026-05-31) — +Operating Expense: 52674000.00
BMNR income_statement (quarterly, 2026-05-31) — +Total Revenue: 46535000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Additional Paid In Capital: 20371935000.00
BMNR income_statement (quarterly, 2026-05-31) — Basic Average Shares: 551788656.00
BMNR income_statement (quarterly, 2026-05-31) — Basic EPS: -0.15
BMNR cash_flow (quarterly, 2026-05-31) — Beginning Cash Position: 879577000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Buildings And Improvements: 1294000.00
BMNR cash_flow (quarterly, 2026-05-31) — Capital Expenditure: -30000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Capital Lease Obligations: 1216000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Capital Stock: 58000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Cash And Cash Equivalents: 340289000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Cash Cash Equivalents And Short Term Investments: 340289000.00
BMNR cash_flow (quarterly, 2026-05-31) — Cash Dividends Paid: 0.00
BMNR balance_sheet (quarterly, 2026-05-31) — Cash Equivalents: 340289000.00
BMNR cash_flow (quarterly, 2026-05-31) — Cash Flow From Continuing Financing Activities: 1791400000.00
BMNR cash_flow (quarterly, 2026-05-31) — Cash Flow From Continuing Investing Activities: -2359661000.00
BMNR cash_flow (quarterly, 2026-05-31) — Cash Flow From Continuing Operating Activities: 29007000.00
BMNR cash_flow (quarterly, 2026-05-31) — Change In Accrued Expense: -4533000.00
BMNR cash_flow (quarterly, 2026-05-31) — Change In Other Current Assets: -24000.00
BMNR cash_flow (quarterly, 2026-05-31) — Change In Other Current Liabilities: 65404000.00
BMNR cash_flow (quarterly, 2026-05-31) — Change In Other Working Capital: -169000.00
BMNR cash_flow (quarterly, 2026-05-31) — Change In Payables And Accrued Expense: -4533000.00
BMNR cash_flow (quarterly, 2026-05-31) — Change In Prepaid Assets: 1031000.00
BMNR cash_flow (quarterly, 2026-05-31) — Change In Working Capital: 62460000.00
BMNR cash_flow (quarterly, 2026-05-31) — Changes In Cash: -539254000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Common Stock: 58000.00
BMNR cash_flow (quarterly, 2026-05-31) — Common Stock Dividend Paid: 0.00
BMNR balance_sheet (quarterly, 2026-05-31) — Common Stock Equity: 11599577000.00
BMNR cash_flow (quarterly, 2026-05-31) — Common Stock Issuance: 2166196000.00
BMNR income_statement (quarterly, 2026-05-31) — Cost Of Revenue: 5726000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Current Accrued Expenses: 9851000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Current Assets: 445261000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Current Deferred Liabilities: 0.00
BMNR balance_sheet (quarterly, 2026-05-31) — Current Deferred Revenue: 0.00
BMNR balance_sheet (quarterly, 2026-05-31) — Current Liabilities: 12138000.00
BMNR cash_flow (quarterly, 2026-05-31) — Depreciation Amortization Depletion: 383000.00
BMNR cash_flow (quarterly, 2026-05-31) — Depreciation And Amortization: 383000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Derivative Product Liabilities: 2087000.00
BMNR income_statement (quarterly, 2026-05-31) — Diluted Average Shares: 551788656.00
BMNR income_statement (quarterly, 2026-05-31) — Diluted EPS: -0.15
BMNR income_statement (quarterly, 2026-05-31) — Diluted NI Availto Com Stockholders: -83576000.00
BMNR income_statement (quarterly, 2026-05-31) — EBIT: -11865000.00
BMNR income_statement (quarterly, 2026-05-31) — EBITDA: -11482000.00
BMNR income_statement (quarterly, 2026-05-31) — Earnings From Equity Interest: -1177000.00
BMNR cash_flow (quarterly, 2026-05-31) — End Cash Position: 340289000.00
BMNR cash_flow (quarterly, 2026-05-31) — Financing Cash Flow: 1791400000.00
BMNR cash_flow (quarterly, 2026-05-31) — Free Cash Flow: 28977000.00
BMNR cash_flow (quarterly, 2026-05-31) — Gain Loss On Investment Securities: 51515000.00
BMNR income_statement (quarterly, 2026-05-31) — Gain On Sale Of Security: -75605000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Gains Losses Not Affecting Retained Earnings: 534000.00
BMNR income_statement (quarterly, 2026-05-31) — General And Administrative Expense: 37270000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Goodwill: 15006000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Goodwill And Other Intangible Assets: 26116000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Gross PPE: 1294000.00
BMNR income_statement (quarterly, 2026-05-31) — Gross Profit: 40809000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Invested Capital: 11599577000.00
BMNR cash_flow (quarterly, 2026-05-31) — Investing Cash Flow: -2359661000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Investments And Advances: 191761000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Investmentsin Joint Venturesat Cost: 191761000.00
BMNR cash_flow (quarterly, 2026-05-31) — Issuance Of Capital Stock: 2166196000.00
BMNR cash_flow (quarterly, 2026-05-31) — Issuance Of Debt: 0.00
BMNR balance_sheet (quarterly, 2026-05-31) — Long Term Capital Lease Obligation: 1216000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Long Term Debt And Capital Lease Obligation: 1216000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Long Term Equity Investment: 191761000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Minority Interest: 548000.00
BMNR income_statement (quarterly, 2026-05-31) — Minority Interests: 19000.00
BMNR cash_flow (quarterly, 2026-05-31) — Net Common Stock Issuance: 2166196000.00
BMNR income_statement (quarterly, 2026-05-31) — Net Income: -83576000.00
BMNR income_statement (quarterly, 2026-05-31) — Net Income Common Stockholders: -83576000.00
BMNR income_statement (quarterly, 2026-05-31) — Net Income Continuous Operations: -83595000.00
BMNR income_statement (quarterly, 2026-05-31) — Net Income From Continuing And Discontinued Operation: -83576000.00
BMNR income_statement (quarterly, 2026-05-31) — Net Income From Continuing Operation Net Minority Interest: -83576000.00
BMNR cash_flow (quarterly, 2026-05-31) — Net Income From Continuing Operations: -83595000.00
BMNR income_statement (quarterly, 2026-05-31) — Net Income Including Noncontrolling Interests: -83595000.00
BMNR income_statement (quarterly, 2026-05-31) — Net Interest Income: 5300000.00
BMNR cash_flow (quarterly, 2026-05-31) — Net Investment Purchase And Sale: -2458211000.00
BMNR cash_flow (quarterly, 2026-05-31) — Net Issuance Payments Of Debt: 0.00
BMNR income_statement (quarterly, 2026-05-31) — Net Non Operating Interest Income Expense: 5300000.00
BMNR cash_flow (quarterly, 2026-05-31) — Net Other Financing Charges: -375089000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Net PPE: 1294000.00
BMNR cash_flow (quarterly, 2026-05-31) — Net PPE Purchase And Sale: 170000.00
BMNR cash_flow (quarterly, 2026-05-31) — Net Preferred Stock Issuance: 0.00
BMNR cash_flow (quarterly, 2026-05-31) — Net Short Term Debt Issuance: 0.00
BMNR balance_sheet (quarterly, 2026-05-31) — Net Tangible Assets: 11573461000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Non Current Deferred Liabilities: 0.00
BMNR balance_sheet (quarterly, 2026-05-31) — Non Current Deferred Taxes Liabilities: 0.00
BMNR balance_sheet (quarterly, 2026-05-31) — Non Current Note Receivables: 93207000.00
BMNR income_statement (quarterly, 2026-05-31) — Normalized EBITDA: 64123000.00
BMNR income_statement (quarterly, 2026-05-31) — Normalized Income: -7971000.00
BMNR cash_flow (quarterly, 2026-05-31) — Operating Cash Flow: 29007000.00
BMNR cash_flow (quarterly, 2026-05-31) — Operating Gains Losses: 58281000.00
BMNR income_statement (quarterly, 2026-05-31) — Operating Income: -11865000.00
BMNR income_statement (quarterly, 2026-05-31) — Operating Revenue: 46535000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Ordinary Shares Number: 579652432.00
BMNR balance_sheet (quarterly, 2026-05-31) — Other Current Assets: 4847000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Other Current Liabilities: 1908000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Other Equity Adjustments: 534000.00
BMNR income_statement (quarterly, 2026-05-31) — Other Gand A: 37270000.00
BMNR income_statement (quarterly, 2026-05-31) — Other Income Expense: -77030000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Other Intangible Assets: 11110000.00
BMNR cash_flow (quarterly, 2026-05-31) — Other Non Cash Items: -31361000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Other Non Current Assets: 10872614000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Other Non Current Liabilities: 14687000.00
BMNR income_statement (quarterly, 2026-05-31) — Other Non Operating Income Expenses: -248000.00
BMNR income_statement (quarterly, 2026-05-31) — Other Operating Expenses: 15404000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Payables And Accrued Expenses: 9851000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Pensionand Other Post Retirement Benefit Plans Current: 379000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Preferred Stock: 0.00
BMNR cash_flow (quarterly, 2026-05-31) — Preferred Stock Issuance: 0.00
BMNR income_statement (quarterly, 2026-05-31) — Pretax Income: -83595000.00
BMNR cash_flow (quarterly, 2026-05-31) — Proceeds From Stock Option Exercised: 293000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Properties: 0.00
BMNR cash_flow (quarterly, 2026-05-31) — Purchase Of Investment: -2458211000.00
BMNR cash_flow (quarterly, 2026-05-31) — Purchase Of PPE: -30000.00
BMNR income_statement (quarterly, 2026-05-31) — Reconciled Cost Of Revenue: 5726000.00
BMNR income_statement (quarterly, 2026-05-31) — Reconciled Depreciation: 383000.00
BMNR cash_flow (quarterly, 2026-05-31) — Repayment Of Debt: 0.00
BMNR balance_sheet (quarterly, 2026-05-31) — Restricted Cash: 100125000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Retained Earnings: -8772950000.00
BMNR cash_flow (quarterly, 2026-05-31) — Sale Of PPE: 200000.00
BMNR income_statement (quarterly, 2026-05-31) — Selling General And Administration: 37270000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Share Issued: 579652432.00
BMNR cash_flow (quarterly, 2026-05-31) — Short Term Debt Issuance: 0.00
BMNR cash_flow (quarterly, 2026-05-31) — Short Term Debt Payments: 0.00
BMNR cash_flow (quarterly, 2026-05-31) — Stock Based Compensation: 13251000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Stockholders Equity: 11599577000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Tangible Book Value: 11573461000.00
BMNR income_statement (quarterly, 2026-05-31) — Tax Effect Of Unusual Items: 0.00
BMNR income_statement (quarterly, 2026-05-31) — Tax Provision: 0.00
BMNR income_statement (quarterly, 2026-05-31) — Tax Rate For Calcs: 0.00
BMNR balance_sheet (quarterly, 2026-05-31) — Total Assets: 11630253000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Total Capitalization: 11599577000.00
BMNR balance_sheet (quarterly, 2026-05-31) — Total Debt: 1216000.00